Antifungal use via outpatient parenteral antimicrobial therapy-Reference-Cited by-同舟云学术

Antifungal use via outpatient parenteral antimicrobial therapy

Published:2022-08-16 Issue:10 Volume:65 Page:946-952
ISSN:0933-7407
Container-title:Mycoses
language:en
Short-container-title:Mycoses

Author:

Chew Su M.¹^ORCID,Heath Christopher H.¹²³⁴,Petursson Cecilia²,Boan Peter A.¹²³,Robinson James Owen¹²³⁵,Italiano Claire M.²,Dyer John R.¹,Manning Laurens¹⁶,Ingram Paul R.¹²³⁴

Affiliation:

1. Department of Infectious Diseases Fiona Stanley Hospital Murdoch WA Australia

2. Department of Microbiology and Infectious Diseases Royal Perth Hospital Perth WA Australia

3. PathWest Laboratory Medicine WA Fiona Stanley Hospital Murdoch WA Australia

4. School of Pathology and Laboratory Medicine University of Western Australia Crawley WA Australia

5. Antimicrobial Resistance and Infectious Diseases Research Laboratory, School of Veterinary and Life Sciences Murdoch University Murdoch WA Australia

6. Medical School University of Western Australia Crawley WA Australia

Publisher

Wiley

Subject

Infectious Diseases,Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/myc.13513

Reference36 articles.

1. Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK

2. Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service

3. Intravenous antimicrobial therapy in the hospital-at-home setting: data from the Spanish Outpatient Parenteral Antimicrobial Therapy Registry

4. Close Patient Follow-up Among Patients Receiving Outpatient Parenteral Antimicrobial Therapy

5. Micafungin may be safely administered as outpatient parenteral antimicrobial therapy for chronic pulmonary aspergillosis

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intermittent micafungin dosing schedule in pediatric oncology patients - safe for Outpatient Parenteral Antimicrobial Therapy?;EJC Paediatric Oncology;2024-09

2. Case Commentary: Extending our therapeutic range against multidrug-resistant Candida;Antimicrobial Agents and Chemotherapy;2024-08-07

3. Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review;Journal of Antimicrobial Chemotherapy;2024-06-06

4. Exploring the advancements of Australian OPAT;Therapeutic Advances in Infectious Disease;2023-01

5. Amphotericin-B-liposomal;Reactions Weekly;2022-11-12